
Geeta Vemuri
QuietNamed in filings at Agent CapitalOn the current fund
- Board seats filed
- 6

Named in filings at Agent CapitalOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Cantai Therapeutics | Biotech & pharma | November 2023 | 82vs |
| Carbon Biosciences | Biotech & pharma | January 2022 | None on file |
| ViTToria Biotherapeutics | Biotech & pharma | July 2021 | None on file |
| Pyxis Oncology | Biotech & pharma | June 2019 | Longwood |
| OncoResponse | Biotech & pharma | September 2015 | ARCH Venture Partners, Greatpoint Ventures Innovation |
| Syntimmune | Biotech & pharma | October 2014 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Geeta Vemuri on the board, based on 6 filed seats with a verified or cited source.